Watpac wins $83M contract to build nuclear medicine facility in New South Wales


Watpac Limited (ASX: WTP) has been awarded a $83 million contract from the Australian Nuclear Science and Technology Organisation to design and construct the Nuclear Medicine Molybdenum-99 facility in Lucas Heights, New South Wales.

The new 4,250 square metre high-tech facility will supply critical life-saving radioisotope Molybdenum-99 to healthcare providers throughout Australia and overseas.

ANSTO has been producing Molybdenum-99 – an active pharmaceutical ingredient used in more than 45 million nuclear medicine diagnostic procedures each year worldwide – for about 40 years and provides half a million doses per annum.

Design work will begin in February 2014 and construction is scheduled for completion in early 2016.

The building is classified as a nuclear installation and will be designed to meet the requirements of the Australian Radiation Protection and Nuclear Safety Agency and Australian Non-proliferation and Safeguards Office.

Watpac’s other current projects include the $148 million Gold Coast Private Hospital, the $65 million Port Macquarie Base Hospital Expansion Project in New South Wales and the $40 million Phase 3 of the Queensland Institute of Medical Research in Brisbane.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Watpac

Price: - -

Market: ASX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Buds & Duds: Cannabis stocks back in the red but make gains overall...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, sank 4.4% at 123 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 5.8% to C$9.55, while the OTCQX Cannabis retreated 4% at...

2 hours, 44 minutes ago

2 min read